- Home
- CRVS vs RMM Comparison
CRVS vs RMM Comparison
Compare CRVS & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- RMM
- Stock Information
- Founded
- CRVS 2014
- RMM 2019
- Country
- CRVS United States
- RMM United States
- Employees
- CRVS N/A
- RMM N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- RMM Trusts Except Educational Religious and Charitable
- Sector
- CRVS Health Care
- RMM Finance
- Exchange
- CRVS Nasdaq
- RMM Nasdaq
- Market Cap
- CRVS 305.4M
- RMM 272.0M
- IPO Year
- CRVS 2016
- RMM N/A
- Fundamental
- Price
- CRVS $4.10
- RMM $13.85
- Analyst Decision
- CRVS Strong Buy
- RMM
- Analyst Count
- CRVS 4
- RMM 0
- Target Price
- CRVS $15.00
- RMM N/A
- AVG Volume (30 Days)
- CRVS 445.0K
- RMM 66.5K
- Earning Date
- CRVS 08-12-2025
- RMM 01-01-0001
- Dividend Yield
- CRVS N/A
- RMM 7.33%
- EPS Growth
- CRVS N/A
- RMM N/A
- EPS
- CRVS N/A
- RMM 0.96
- Revenue
- CRVS N/A
- RMM N/A
- Revenue This Year
- CRVS N/A
- RMM N/A
- Revenue Next Year
- CRVS N/A
- RMM N/A
- P/E Ratio
- CRVS N/A
- RMM $15.55
- Revenue Growth
- CRVS N/A
- RMM N/A
- 52 Week Low
- CRVS $2.47
- RMM $12.32
- 52 Week High
- CRVS $10.00
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- CRVS 44.93
- RMM 57.35
- Support Level
- CRVS $4.58
- RMM $13.74
- Resistance Level
- CRVS $4.98
- RMM $13.86
- Average True Range (ATR)
- CRVS 0.23
- RMM 0.12
- MACD
- CRVS -0.04
- RMM -0.01
- Stochastic Oscillator
- CRVS 13.79
- RMM 37.14
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.